Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

X4 Pharmaceuticals, Inc

Report initial data from the Phase 1b Waldenström's trial

Delivered by the deadline

AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.

Announced
4 Mar 2021
Due
30 Jun 2021
Delivered
June 2021
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“we continue to expect initial data from that study in the first half of 2021”

What we found

Evidence strength A What the grades mean

The company presented low- and mid-dose Waldenström's Phase 1b data at EHA in June 2021, before the June 30, 2021 deadline, per later filings.

  • A
    X4 Pharmaceuticals, Inc 8-K filed 2021-08-03 Regulatory filing · published 3 Aug 2021 · retrieved 27 Oct 2026 · kept permanently by the SEC
    “EHA 2021: In June, the company announced the presentation of positive data from its ongoing Phase 1b clinical trial of mavorixafor in combination with ibrutinib in Waldenström’s” ✓ confirmed on the page
  • A
    X4 Pharmaceuticals, Inc 8-K filed 2021-08-03 Regulatory filing · published 3 Aug 2021 · retrieved 27 Oct 2026 · kept permanently by the SEC
    “that we believe will build on the low- and mid-dose data we presented at EHA this past June” ✓ confirmed on the page

Checked 27 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical readout
Indicative materiality
Medium rules
Action
Report
Deliverable
Initial data from Phase 1b Waldenström's trial
Language
Expected (“expects”, “plans”)
In the company’s control
Low
Specificity
Medium

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.

Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works

Are you X4 Pharmaceuticals, Inc? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-XFOR-025211 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.